JP2014031330A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014031330A5 JP2014031330A5 JP2012172580A JP2012172580A JP2014031330A5 JP 2014031330 A5 JP2014031330 A5 JP 2014031330A5 JP 2012172580 A JP2012172580 A JP 2012172580A JP 2012172580 A JP2012172580 A JP 2012172580A JP 2014031330 A5 JP2014031330 A5 JP 2014031330A5
- Authority
- JP
- Japan
- Prior art keywords
- amylase inhibitor
- food
- inhibitor according
- composition
- beverage products
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 101710171801 Alpha-amylase inhibitor Proteins 0.000 claims 4
- 239000003392 amylase inhibitor Substances 0.000 claims 4
- 235000013305 food Nutrition 0.000 claims 3
- 235000013361 beverage Nutrition 0.000 claims 2
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical class C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims 2
- 235000003392 Curcuma domestica Nutrition 0.000 claims 1
- 244000008991 Curcuma longa Species 0.000 claims 1
- 208000002249 Diabetes Complications Diseases 0.000 claims 1
- 206010012655 Diabetic complications Diseases 0.000 claims 1
- 208000001145 Metabolic Syndrome Diseases 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 235000003373 curcuma longa Nutrition 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 201000001421 hyperglycemia Diseases 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 230000000069 prophylactic effect Effects 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 235000013976 turmeric Nutrition 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012172580A JP2014031330A (ja) | 2012-08-03 | 2012-08-03 | 高血糖等改善剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012172580A JP2014031330A (ja) | 2012-08-03 | 2012-08-03 | 高血糖等改善剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014031330A JP2014031330A (ja) | 2014-02-20 |
| JP2014031330A5 true JP2014031330A5 (https=) | 2015-09-10 |
Family
ID=50281469
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012172580A Pending JP2014031330A (ja) | 2012-08-03 | 2012-08-03 | 高血糖等改善剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2014031330A (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023213813A1 (en) * | 2022-05-03 | 2023-11-09 | Universiteit Maastricht | Compound for use in the regulation of saccharide absorption via the gastrointestinal tract and compositions thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI329516B (en) * | 2000-12-12 | 2010-09-01 | Kaneka Corp | Composition for preventing or ameliorating multiple risk factor syndromes and visceral fat-type obesity |
| WO2007043058A1 (en) * | 2005-10-13 | 2007-04-19 | Ganga Raju Gokaraju | Process for producing enriched fractions of tetrahydroxycurcumin and tetrahydrotetrahydroxy-curcumin from the extracts of curcuma longa |
-
2012
- 2012-08-03 JP JP2012172580A patent/JP2014031330A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2013133685A8 (en) | Extract formulations of rhodamnia cinerea and uses thereof | |
| WO2016105118A3 (ko) | Gpr120 효능제로서의 바이아릴 유도체 | |
| HK1211231A1 (en) | Exendin-4 derivatives | |
| EP3016527A4 (en) | Treatment of obesity, the metabolic syndrome, type 2 diabetes, cardiovascular diseases, dementia, alzheimer's disease and inflammatory bowel disease by using at least one bacterial strain from prevotella | |
| WO2007104789A3 (en) | Amylin derivatives | |
| TN2016000558A1 (en) | Fatty acids and their use in conjugation to biomolecules | |
| WO2012094636A3 (en) | Chemosensory receptor ligand-based therapies | |
| CO6771409A2 (es) | Acidos 1-bencilcicloalquilcarboxilicos sustituidos y su uso | |
| WO2011083998A3 (ko) | 바이구아나이드 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 약학 조성물 | |
| JP2013520167A5 (https=) | ||
| MX2011011178A (es) | Compuesto de diaciletilendiamina. | |
| MX378007B (es) | Derivados de biarilo como agonistas de gpr120. | |
| JP2018530592A5 (https=) | ||
| BR112012033180A2 (pt) | ''unidade de infusão para a produção de bebidas quentes por meio da extração de um produto carregado em uma câmara de infusão, câmara de infusão, e máquina de preparação de uma bebida que compreende uma unidade de infusão'' | |
| WO2015095354A3 (en) | Compositions and methods for treating fatty tissue buildup | |
| EP2646032A4 (en) | THERAPEUTIC TREATMENT OF METABOLIC SYNDROME AND TYPE 2 DIABETES, ADIPOSITAS OR PREDICTES | |
| WO2010117979A3 (en) | Serotonin and norepinephrine reuptake inhibitor | |
| JP2014031330A5 (https=) | ||
| BRPI0924418A2 (pt) | composições e métodos para a prevenção e o tratamento de obesidade e síndrome metabólica relacionada à obesidade | |
| WO2012033353A3 (ko) | 세스터터핀 화합물 및 이들 물질의 용도 | |
| JP2014533256A5 (https=) | ||
| CL2013001332A1 (es) | Composicion farmaceutica adaptada para administrarse oralmente, a base de un modificador de la motilidad intestinal y alfa-d-galactosidasa; proceso para su preparacion; y uso en la prevencion y el tratamiento del sindrome de intestino irritable. | |
| IN2015DN03104A (https=) | ||
| JP2014101346A5 (https=) | ||
| WO2015039036A3 (en) | Novel cytochrome p450 inhibitors and their method of use |